CERE — CEREVEL THERAPEUTICS HLDNG I
What is a 13F filing? Who files one and when · What 13F filings can't tell you
Last updated: 2026-10-24 · Source: SEC EDGAR Form 13F-HR
CERE (CEREVEL THERAPEUTICS HLDNG I) is tracked on HoldingsHub across five years of quarterly 13F filings. 288 funds have reported positions historically, with the sum of their latest reported stakes valued at $6.45B. No fund in our coverage reported a position in the latest filing period, which typically means the stock has fallen out of the tracked funds' portfolios rather than that it cannot be bought.
Major shareholders of CEREVEL THERAPEUTICS HLDNG I (CERE) include BAIN CAPITAL INVESTORS LLC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, ranked by reported 13F value among the 288 institutional holders on this page.
All figures on this page are computed from SEC Form 13F quarterly filings. 13F filers disclose long positions of $100,000 or more within 45 days of quarter end; short positions, options overlays and intra-quarter trades are not included, so treat the numbers as a quarterly snapshot of institutional ownership rather than real-time positioning.
Institutional Ownership by Quarter
| Quarter | Funds holding | Shares | Value | QoQ Net Change |
|---|---|---|---|---|
| Q3 2024 | 2 | 472 | $20.69K | -46.5% |
| Q2 2024 | 223 | 148.34M | $6.06B | -1.7% |
| Q1 2024 | 202 | 147.80M | $6.23B | -0.2% |
| Q4 2023 | 191 | 148.04M | $6.25B | -8.4% |
| Q3 2023 | 121 | 143.56M | $3.01B | +5.3% |
| Q2 2023 | 28 | 40.68M | $1.13B | -1.8% |
| Q1 2023 | 28 | 41.52M | $885.00M | -1.3% |
| Q4 2022 | 29 | 41.46M | $1.16B | -0.6% |
Over the 8 quarters shown, institutional share counts decreased 100% in aggregate (Q4 2022 → Q3 2024); the largest single-quarter swing was Q4 2023 (-8.4%).
Top Institutional Holders (Q3 2024) — 2 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 346 | $15.53K | 0.00% | Reduce | |
| 126 | $5.15K | 0.00% | Add |
Holder history for earlier quarters, one table per quarter: Back to the Top 25 holders
Q2 2024 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 65.68M | $2.69B | 57.02% | Hold | |
| 10.79M | $441.40M | 10.76% | Hold | |
| 7.54M | $308.29M | 4.11% | Hold | |
| 7.15M | $292.54M | 0.01% | Reduce | |
| 3.25M | $132.97M | 0.13% | Hold | |
| 3.11M | $127.16M | 0.01% | Reduce | |
| 2.96M | $121.07M | 0.06% | Add | |
| 2.35M | $96.24M | 4.60% | Add | |
| 2.34M | $95.51M | 0.01% | Add | |
| 2.33M | $95.29M | 3.65% | Hold | |
| 2.15M | $87.98M | 2.21% | Add | |
| 1.87M | $76.44M | 0.14% | Add | |
| 1.49M | $61.10M | 0.02% | Add | |
| 1.47M | $60.11M | 0.01% | Reduce | |
| 1.35M | $55.11M | 0.01% | Add | |
| 1.28M | $52.51M | 0.12% | Reduce | |
| 1.23M | $50.44M | 0.16% | Add | |
| 1.19M | $48.66M | 0.21% | Add | |
| 1.19M | $48.66M | 0.23% | New | |
| 1.10M | $44.95M | 3.97% | Add | |
| 1.04M | $42.49M | 0.98% | Add | |
| 1.02M | $41.75M | 0.02% | Hold | |
| 1.01M | $41.47M | 0.91% | Hold | |
| 919.02K | $37.58M | 10.99% | New | |
| 766.93K | $31.36M | 3.33% | Reduce |
Q1 2024 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 65.68M | $2.78B | 61.94% | Hold | |
| 10.79M | $456.30M | 8.29% | Reduce | |
| 7.56M | $319.37M | 3.73% | Hold | |
| 7.46M | $315.50M | 0.01% | Add | |
| 3.53M | $149.15M | 0.01% | Add | |
| 3.25M | $137.34M | 0.14% | Add | |
| 2.34M | $98.97M | 3.86% | Add | |
| 2.33M | $98.51M | 3.47% | Hold | |
| 2.22M | $93.84M | 2.07% | Add | |
| 1.94M | $82.01M | 2.11% | New | |
| 1.90M | $80.11M | 0.19% | Add | |
| 1.87M | $79.24M | 0.01% | Add | |
| 1.79M | $75.76M | 0.01% | Reduce | |
| 1.60M | $67.63M | 0.85% | Hold | |
| 1.57M | $66.54M | 0.03% | Add | |
| 1.22M | $51.67M | 0.11% | Add | |
| 1.17M | $49.58M | 0.02% | Add | |
| 1.08M | $45.53M | 0.18% | Add | |
| 1.06M | $44.93M | 0.19% | Add | |
| 1.02M | $43.05M | 1.03% | Hold | |
| 1.02M | $42.99M | 0.02% | Add | |
| 977.55K | $41.32M | 0.15% | Add | |
| 944.36K | $39.92M | 2.74% | Add | |
| 828.78K | $35.03M | 0.16% | Add | |
| 788.87K | $33.35M | 3.76% | Add |
Q4 2023 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 65.68M | $2.78B | 60.38% | Add | |
| 10.97M | $464.92M | 10.44% | Add | |
| 9.69M | $410.93M | 0.03% | Reduce | |
| 7.56M | $320.36M | 4.42% | Add | |
| 7.37M | $312.70M | 0.01% | Add | |
| 2.85M | $120.92M | 0.01% | Reduce | |
| 2.77M | $117.28M | 0.12% | New | |
| 2.67M | $113.39M | 2.93% | Add | |
| 2.33M | $98.81M | 4.76% | Reduce | |
| 1.79M | $75.88M | 0.01% | Add | |
| 1.73M | $73.14M | 2.55% | New | |
| 1.64M | $69.71M | 3.58% | New | |
| 1.60M | $67.84M | 0.78% | New | |
| 1.13M | $48.02M | 0.02% | Add | |
| 1.11M | $47.11M | 0.08% | Reduce | |
| 1.11M | $47.11M | 0.02% | Reduce | |
| 1.10M | $46.64M | 1.17% | New | |
| 1.02M | $43.18M | 1.17% | New | |
| 933.76K | $39.59M | 1.99% | New | |
| 900.02K | $38.16M | 0.15% | New | |
| 863.79K | $36.62M | 0.01% | New | |
| 785.49K | $33.30M | 0.19% | Reduce | |
| 755.95K | $32.05M | 0.00% | Add | |
| 750.00K | $31.80M | 6.86% | Add | |
| 721.05K | $30.57M | 0.00% | Reduce |
Q3 2023 — 25 funds
Q2 2023 — 25 funds
| Fund | Shares | Value | Portfolio Weight | Change |
|---|---|---|---|---|
| 23.49M | $746.87M | 0.07% | Hold | |
| 5.66M | $180.01M | 0.00% | Reduce | |
| 1.35M | $42.79M | 0.01% | Add | |
| 984.00K | $31.28M | 0.02% | Reduce | |
| 699.70K | $22.24M | 0.04% | Reduce | |
| 583.28K | $18.54M | 0.00% | Add | |
| 501.98K | $15.96M | 0.01% | Add | |
| 363.70K | $11.56M | 0.00% | Reduce | |
| 260.10K | $8.27M | 0.00% | Add | |
| 179.79K | $5.72M | 0.00% | Reduce | |
| 170.58K | $5.42M | 0.00% | Add | |
| 161.35K | $5.13M | 0.00% | Add | |
| 160.70K | $5.11M | 0.00% | Reduce | |
| 156.66K | $4.98M | 0.00% | Reduce | |
| 146.10K | $4.64M | 0.00% | Add | |
| 140.55K | $4.47M | 0.00% | Reduce | |
| 110.75K | $3.52M | 0.01% | Reduce | |
| 68.28K | $2.17M | 0.00% | Reduce | |
| 63.63K | $2.02M | 0.00% | Add | |
| 57.52K | $1.83M | 0.00% | Add | |
| 32.37K | $1.03M | 0.00% | Add | |
| 32.30K | $1.03M | 0.00% | Add | |
| 29.33K | $932.34K | 0.00% | Reduce | |
| 26.57K | $844.72K | 0.00% | Reduce | |
| 7.02K | $223.20K | 0.00% | Reduce |
New Positions (latest)
No fund opened a new position this quarter.
Fully Exited (vs previous quarter)
No tracked fund fully exited this quarter.
Fund Position History — shares by quarter (top 20 funds)
| Fund | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 | Q4 2020 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| IFP Advisors, Inc | 346 | 764 | 764 | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Blue Trust, Inc. | 126 | 119 | 96 | 133 | — | — | — | — | — | — | — | — | — | — | — | — |
| BAIN CAPITAL INVESTORS LLC | — | 65.68M | 65.68M | 65.68M | 60.20M | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity Management & Research (FMR) | — | 4.88K | 1.79M | 9.69M | 23.62M | 23.49M | 23.47M | 23.42M | 23.32M | 22.24M | 22.20M | 19.51M | 18.81M | — | — | — |
| PERCEPTIVE ADVISORS LLC | — | 10.79M | 10.79M | 10.97M | 10.09M | — | — | — | — | — | — | — | — | — | — | — |
| Avoro Capital Advisors LLC | — | 7.54M | 7.56M | 7.56M | 955.55K | — | — | — | — | — | — | — | — | — | — | — |
| Vanguard Group | — | 7.15M | 7.46M | 7.37M | 6.37M | 5.66M | 6.13M | 6.04M | 5.87M | 5.01M | 4.81M | 4.80M | 4.69M | 3.52M | 3.23M | — |
| STATE STREET CORP | — | 3.11M | 3.53M | 2.85M | 2.90M | — | — | — | — | — | — | — | — | — | — | — |
| Fidelity International (FIL) | — | 3.25M | 3.25M | 2.77M | — | — | — | — | — | — | — | — | — | — | — | — |
| PRICE T ROWE ASSOCIATES INC /MD/ | — | 53.40K | 335.36K | 721.05K | 5.50M | — | — | — | — | — | — | — | — | — | — | — |
| Rock Springs Capital Management LP | — | — | 547.95K | 2.67M | 2.53M | — | — | — | — | — | — | — | — | — | — | — |
| ALPINE ASSOCIATES MANAGEMENT INC. | — | 2.35M | 2.34M | 1.64M | — | — | — | — | — | — | — | — | — | — | — | — |
| Paradigm Biocapital Advisors LP | — | 2.33M | 2.33M | 2.33M | 2.53M | — | — | — | — | — | — | — | — | — | — | — |
| Norges Bank Investment Management | — | 2.34M | 725.05K | 685.69K | 546.97K | — | — | 174.54K | — | — | — | — | — | — | — | — |
| Pentwater Capital Management LP | — | 400.00K | 2.22M | 1.10M | — | — | — | — | — | — | — | — | — | — | — | — |
| Soros Fund Management | — | 2.15M | 1.94M | — | — | — | — | — | — | — | — | — | — | — | — | — |
| Citigroup Inc | — | 1.28M | 1.90M | 29.90K | 83.79K | 68.28K | 228.79K | 152.76K | 139.60K | 78.86K | 20.70K | 122.05K | 196.49K | — | — | — |
| Geode Capital Management | — | 1.47M | 1.87M | 1.79M | 1.44M | 1.35M | 1.26M | 1.20M | 1.13M | 1.05M | 925.70K | 928.77K | 909.12K | — | — | — |
| Marshall Wace | — | 1.87M | 1.22M | 312.96K | — | — | — | — | — | — | — | — | — | — | — | — |
| OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM | — | — | — | 1.73M | — | — | — | — | — | — | — | — | — | — | — | — |
FAQ
Which funds hold CERE?
288 funds have reported positions in CERE across five years of 13F filings; the sum of their latest reported stakes is $6.45B.
Who are the top institutional holders of CERE?
The largest 13F holders are BAIN CAPITAL INVESTORS LLC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, Vanguard Group, Fidelity International (FIL); the top 25 are ranked at the top of this page.
Who are the major shareholders of CEREVEL THERAPEUTICS HLDNG I?
The major shareholders of CEREVEL THERAPEUTICS HLDNG I (CERE) by reported 13F value are BAIN CAPITAL INVESTORS LLC, PERCEPTIVE ADVISORS LLC, Avoro Capital Advisors LLC, Vanguard Group, Fidelity International (FIL), among 288 institutional holders.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.